FDA Approves New Treatments for Colorectal Cancer, Leukemia, and Melanoma
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
Category: Policy
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
Policymakers, parents, teachers, and public health professionals have all expressed concern about the rise in teen vaping and a...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab...
This week, President Trump signed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act, which is aimed at...
On May 4, the U.S. Food and Drug Administration (FDA) approved a combination of molecularly targeted therapeutics for the...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved expanding the use of the immunotherapeutic tisagenlecleucel (Kymriah)...
Early this week, the U.S. Food and Drug Administration (FDA) approved a combination immunotherapy regimen for treating certain patients...
Each year, the American Association for Cancer Research (AACR) is proud to bring Associate Members to Washington, D.C., where...
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the immunotherapeutic durvalumab (Imfinzi) to include...
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...